WO2018181918A1 - 筒状構造体 - Google Patents
筒状構造体 Download PDFInfo
- Publication number
- WO2018181918A1 WO2018181918A1 PCT/JP2018/013681 JP2018013681W WO2018181918A1 WO 2018181918 A1 WO2018181918 A1 WO 2018181918A1 JP 2018013681 W JP2018013681 W JP 2018013681W WO 2018181918 A1 WO2018181918 A1 WO 2018181918A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- cylindrical
- cylindrical structure
- woven fabric
- fabric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/04—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3653—Interfaces between patient blood circulation and extra-corporal blood circuit
- A61M1/3655—Arterio-venous shunts or fistulae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3653—Interfaces between patient blood circulation and extra-corporal blood circuit
- A61M1/3659—Cannulae pertaining to extracorporeal circulation
- A61M1/3661—Cannulae pertaining to extracorporeal circulation for haemodialysis
-
- D—TEXTILES; PAPER
- D03—WEAVING
- D03D—WOVEN FABRICS; METHODS OF WEAVING; LOOMS
- D03D13/00—Woven fabrics characterised by the special disposition of the warp or weft threads, e.g. with curved weft threads, with discontinuous warp threads, with diagonal warp or weft
- D03D13/004—Woven fabrics characterised by the special disposition of the warp or weft threads, e.g. with curved weft threads, with discontinuous warp threads, with diagonal warp or weft with weave pattern being non-standard or providing special effects
-
- D—TEXTILES; PAPER
- D03—WEAVING
- D03D—WOVEN FABRICS; METHODS OF WEAVING; LOOMS
- D03D3/00—Woven fabrics characterised by their shape
- D03D3/02—Tubular fabrics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2401/00—Physical properties
- D10B2401/06—Load-responsive characteristics
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
- F16L—PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
- F16L58/00—Protection of pipes or pipe fittings against corrosion or incrustation
- F16L58/02—Protection of pipes or pipe fittings against corrosion or incrustation by means of internal or external coatings
- F16L58/04—Coatings characterised by the materials used
- F16L58/10—Coatings characterised by the materials used by rubber or plastics
Definitions
- the present invention relates to a cylindrical structure.
- An artificial blood vessel is a medical device used to replace a pathological biological blood vessel such as arteriosclerosis or to form a bypass. Among them, it is common to treat patients with chronic renal failure by artificial dialysis, and a dialysis shunt is used to ensure a sufficient blood flow for extracorporeal circulation.
- a dialysis shunt is a term for an artificial blood vessel used as an arterial-venous (AV) shunt that bypasses an artery and a vein.
- AV arterial-venous
- a typical artificial blood vessel used for a shunt includes an artificial blood vessel made of expanded polytetrafluoroethylene (hereinafter referred to as ePTFE).
- ePTFE expanded polytetrafluoroethylene
- Patent Documents 1 to 5 In order to solve this problem, reported is an example in which puncture resistance is imparted by coating an outer layer of a conventional artificial blood vessel made of ePTFE with an elastomeric polymer such as silicone, polyurethane and polystyrene.
- a living blood vessel has an intima on the inner surface, and it can inhibit thrombosis by having vascular endothelial cells.
- conventional artificial blood vessels made of ePTFE have low cell affinity, and vascular endothelial cells are not fixed. Not only is it difficult to occur, it takes time to establish vascular endothelial cells and to form the intima.
- an artificial blood vessel has been reported that promotes the proliferation of vascular endothelial cells to the porous portion and stabilizes in vivo for a long period of time by using a porous structure made of polyester-based fibers having elasticity as a base material.
- Patent Document 6 this artificial blood vessel is provided with puncture resistance by coating the outer layer with silicone or a polystyrene-based elastomer or the like in order to provide sealing properties after puncture.
- the artificial blood vessels described in Patent Documents 1 to 5 suffer from loss of flexibility because the elastomeric polymer used for the covering material is highly elastic.
- the flexibility of the artificial blood vessel is impaired, for example, it becomes difficult to puncture the dialysis needle when performing dialysis, or a foreign body sensation is caused by embedding a hard artificial blood vessel, and the patient's QOL (Quality Of Life) ) And other problems occur.
- the artificial blood vessel described in Patent Document 1 provides puncture resistance by wrapping 10 layers of an ePTFE sheet having a thickness of 80 ⁇ m around a base material, but is not satisfactory water leakage.
- the ePTFE base material is coated with a styrene-based elastomer or a polymer composed of low molecular weight ethylene / vinyl acetate, so that a certain degree of kink resistance is obtained due to the effect of the elastomer layer. Performance and puncture resistance, but not satisfactory performance.
- Patent Document 3 which includes the step of winding the ePTFE sheet around the ePTFE substrate and turning it over, generates compression elasticity in the tube through the step of turning over, and imparts puncture resistance. Since the tape is wound several times, it can be assumed that there is not enough kink resistance.
- the artificial blood vessel described in Patent Document 6 is presumed to maintain the flexibility of the original base material because the silicone layer is thin.
- the dialysis needle often used in artificial dialysis in clinical settings is 16G, which is a slightly thicker needle. It is not enough because it is necessary to make a hole.
- the artificial blood vessel for inner shunt described in Patent Document 7 achieves low water leakage due to the excellent elasticity of polyurethane, but polyurethane is known to deteriorate in strength if it is left in vivo for a long period of time, There is a possibility that puncture resistance cannot be maintained for a long time.
- an object of the present invention is to provide a cylindrical structure in which water leakage after puncturing with a needle piercing member is reduced without impairing the flexibility of the base material.
- a cylindrical base material and a covering material that covers the base material including a copolymer having a silicone monomer and a polymerizable monomer having a fluoroalkyl group as a monomer unit, Tubular structure.
- the said silicone monomer is a cylindrical structure of (1) description shown by the following general formula (I).
- X 1 and X 2 each independently represent a polymerizable functional group
- R 1 to R 8 each independently represent hydrogen, an alkyl group having 1 to 20 carbon atoms, a phenyl group, and 1 to A functional group selected from the group consisting of 20 fluoroalkyl groups is represented
- L 1 and L 2 each independently represent a divalent group
- m and n each independently represent an integer of 0 to 1500. However, m and n are not 0 at the same time.
- the polymerizable monomer having a fluoroalkyl group is a cylindrical structure according to any one of (1) to (3), which is represented by the following general formula (II). [Wherein R 9 represents hydrogen or a methyl group, and R 10 represents a fluoroalkyl group having 1 to 20 carbon atoms. ] (5) When the surface of the coating material is measured at a wavelength of 2.5 to 25 ⁇ m and an incident angle of 45 ° using single reflection infrared spectroscopy, the following equation 1 is satisfied: (1) to ( The cylindrical structure according to any one of 4).
- I 2 is 1430 ⁇ based on C-H deformation vibration from alkyl 1470 cm -1 Represents the absorbance.
- the said copolymer is a cylindrical structure of (5) or (6) description containing the structure shown by the following general formula (III). [Wherein R 9 represents hydrogen or a methyl group, and L 3 represents a monovalent group.
- the cylindrical base material is a cylindrical woven fabric having warps and wefts, and the cylindrical woven fabric has a difference in outer diameter in the warp direction within 10%, and the following formula 2
- the cylindrical base material is a cylindrical woven fabric having warps and wefts, and the cylindrical woven fabric satisfies any one of the following formula 3: (1) to (9) Cylindrical structure.
- a represents the maximum outer diameter of the fabric when compressed in the warp direction with a stress of 0.01 cN / dtex
- b represents the maximum diameter when stretched in the warp direction with a stress of 0.01 cN / dtex. Expresses the minimum outer diameter of the fabric.
- (11) The cylindrical structure according to any one of (1) to (10), which is a medical tube that can be implanted in a living body.
- (12) The cylindrical structure according to any one of (1) to (10), which is an artificial blood vessel.
- the cylindrical structure of the present invention is a medical tube, particularly an artificial blood vessel or a dialysis shunt that can be implanted in a living body without impairing the flexibility of the base material and reducing water leakage after puncturing with a needle piercing member. It can be particularly preferably used.
- the cylindrical structure of the present invention includes a cylindrical base material and a coating material that covers the base material, and the coating material has a monomer unit that includes a silicone monomer and a polymerizable monomer having a fluoroalkyl group. It is characterized by containing a polymer.
- the copolymer refers to a copolymer that forms a crosslinked structure by chemically bonding each molecule with a monomer having two or more polymerizable functional groups as a monomer unit.
- the chemical bond here includes covalent bond, ionic bond, hydrogen bond, hydrophobic interaction, ⁇ - ⁇ stacking, etc., and is not particularly limited, but insolubilization in various solvents, heat resistance, elastic modulus and elongation. From the viewpoint of mechanical properties such as degree, a covalent bond is preferable.
- the above-mentioned copolymer is preferably less in swelling due to contact with the liquid in order to maintain the adhesion to the base material. Therefore, the water content is preferably 10% by weight or less, more preferably 5% or less. Preferably, 2% or less is more preferable, and 1% or less is most preferable.
- the lower limit of the tensile modulus of the copolymer is preferably 0.1 MPa or more, more preferably 0.2 MPa or more, and further preferably 0.3 MPa or more.
- the upper limit of the tensile modulus of the copolymer is preferably 20 MPa or less, more preferably 10 MPa or less, still more preferably 0.8 MPa or less, and most preferably 0.6 MPa or less.
- the lower limit of the tensile elongation (breaking elongation) of the above copolymer is 50% or more, preferably 150% or more, more preferably 170% or more, further preferably 200% or more, and more than 400%. Most preferred. Further, the upper limit of the tensile elongation of the above copolymer is 3000% or less, more preferably 2500% or less, further preferably 2000% or less, and most preferably 1000% or less.
- the silicone monomer in the copolymer is preferably a polydimethylsiloxane compound having a plurality of polymerizable functional groups per monomer. Moreover, it is preferable that it is a copolymer and a copolymer with the compound different from the said polydimethylsiloxane compound is made into a main component.
- the main component means a component that is contained in an amount of 50% by weight or more based on the weight of the dry substrate (100% by weight).
- the number average molecular weight of the silicone monomer is preferably 6,000 or more. The inventors have found that when the number average molecular weight of the silicone monomer is within this range, a copolymer having flexibility and excellent mechanical properties such as kink resistance can be obtained.
- the number average molecular weight of the silicone monomer is preferably in the range of 8,000 to 100,000, more preferably in the range of 9,000 to 70,000, and in the range of 10,000 to 50,000. Most preferred.
- the dispersity of the silicone monomer is preferably 6 or less, more preferably 3 or less, still more preferably 2 or less, and most preferably 1.5 or less.
- the number average molecular weight of the silicone monomer is a number average molecular weight in terms of polystyrene measured by a gel permeation chromatography method (GPC method) using chloroform as a solvent.
- the weight average molecular weight and the degree of dispersion are also measured by the same method.
- the silicone monomer is a silicone monomer having a polymerizable functional group.
- the number of polymerizable functional groups in the silicone monomer may be one or more per monomer, but from the viewpoint that more flexible (low elastic modulus) property is easily obtained, two is preferable per monomer.
- a structure having a polymerizable functional group at both ends of the molecular chain is preferable.
- the polymerizable functional group possessed by the silicone monomer is preferably a functional group capable of radical polymerization, and more preferably a functional group having a carbon-carbon double bond.
- Preferable polymerizable functional groups include, for example, vinyl group, allyl group, (meth) acryloyl group, ⁇ -alkoxymethylacryloyl group, maleic acid residue, fumaric acid residue, itaconic acid residue, crotonic acid residue, isocrotone Examples include acid residues and citraconic acid residues. Of these, a (meth) acryloyl group is most preferred because of its high polymerizability.
- (meth) acryloyl represents both methacryloyl and acryloyl, and the same applies to terms such as (meth) acryl and (meth) acrylate.
- a monomer represented by the following general formula (I) is preferable.
- X 1 and X 2 each independently represent a polymerizable functional group
- R 1 to R 8 each independently represent hydrogen, an alkyl group having 1 to 20 carbon atoms, a phenyl group, and 1 to 20 carbon atoms.
- L 1 and L 2 each independently represent a divalent group
- m and n are each independently an integer of 0 to 1500 Represents. However, m and n are not 0 at the same time.
- X 1 and X 2 are preferably radically polymerizable functional groups among polymerizable functional groups, and preferably have a carbon-carbon double bond.
- the polymerizable functional group include a vinyl group, allyl group, (meth) acryloyl group, ⁇ -alkoxymethylacryloyl group, maleic acid residue, fumaric acid residue, itaconic acid residue, crotonic acid residue, isocrotonic acid. Residues and citraconic acid residues. Of these, a (meth) acryloyl group is most preferred because of its high polymerizability.
- R 1 to R 8 are hydrogen; those having 1 to 20 carbon atoms such as methyl group, ethyl group, propyl group, isopropyl group, butyl group, t-butyl group, decyl group, dodecyl group and octadecyl group.
- Alkyl group phenyl group, trifluoromethyl group, trifluoroethyl group, trifluoropropyl group, tetrafluoropropyl group, hexafluoroisopropyl group, pentafluorobutyl group, heptafluoropentyl group, nonafluorohexyl group, hexafluorobutyl group , Heptafluorobutyl group, octafluoropentyl group, nonafluoropentyl group, dodecafluoroheptyl group, tridecafluoroheptyl group, dodecafluorooctyl group, tridecafluorooctyl group, hexadecafluorodecyl group, heptadecafluorodecyl group, Tetrafluorop Propyl group, a pentafluoropropyl group, tetradecanoyl per
- L 1 and L 2 are preferably divalent groups having 1 to 20 carbon atoms.
- L 1 and L 2 are preferably groups represented by the following formulas (LE1) to (LE12) because they have the advantage of being easily obtained with high purity.
- the following formula (LE1) ⁇ (LE12) the terminal of the left is attached to the polymerizable functional group X 1 or X 2, is depicted as an end of the right side is attached to a silicon atom.
- m and n each independently represent the number of each repeating unit.
- m and n each independently represents an integer of 0 to 1500.
- the total value of m and n (m + n) is preferably 80 or more, more preferably 100 or more, more preferably 100 to 1400, still more preferably 120 to 950, and most preferably 130 to 700.
- R 1 to R 8 are all methyl groups
- n 0, and m is preferably 80 to 1500, more preferably 100 to 1400, still more preferably 120 to 950, and most preferably 130 to 700.
- the value of m depends on the molecular weight of the silicone monomer.
- the above silicone monomer may be used alone or in combination of two or more.
- a polymerizable monomer having a fluoroalkyl group represented by the following general formula (II) is preferable.
- R 9 represents hydrogen or a methyl group
- R 10 represents a fluoroalkyl group having 1 to 20 carbon atoms.
- Suitable specific examples of the fluoroalkyl group having 1 to 20 carbon atoms as R 10 include a trifluoromethyl group, a trifluoroethyl group, a trifluoropropyl group, a tetrafluoropropyl group, a hexafluoroisopropyl group, a pentafluorobutyl group, Heptafluoropentyl, nonafluorohexyl, hexafluorobutyl, heptafluorobutyl, octafluoropentyl, nonafluoropentyl, dodecafluoroheptyl, tridecafluoroheptyl, dodecafluorooctyl, tridecafluorooctyl Group, hexadecafluorodecyl group, heptadecafluorodecyl group, tetrafluoropropyl group, penta
- the copolymer is flexible and has excellent mechanical properties such as kink resistance.
- Only one type of polymerizable monomer having the above fluoroalkyl group may be used, or two or more types may be used in combination.
- the content of the polymerizable monomer having a fluoroalkyl group in the copolymer is preferably 10 to 500 parts by weight, more preferably 20 to 400 parts by weight, and still more preferably 20 to 200 parts by weight with respect to 100 parts by weight of the silicone monomer. Part. When the amount used is too small, mechanical properties such as kink resistance tend to be insufficient.
- a different monomer may be further copolymerized as the copolymer in the cylindrical structure.
- the different monomer one that lowers the glass transition point of the copolymer to room temperature or below 0 ° C. is preferable. Since these reduce the cohesive energy, they have the effect of imparting rubber elasticity and softness to the copolymer.
- the polymerizable functional group of different monomers is preferably a radically polymerizable functional group, more preferably a carbon-carbon double bond.
- preferred polymerizable functional groups include vinyl group, allyl group, (meth) acryloyl group, ⁇ -alkoxymethylacryloyl group, maleic acid residue, fumaric acid residue, itaconic acid residue, crotonic acid residue, isocrotonic acid
- acid residue and citraconic acid residue include a (meth) acryloyl group because of high polymerizability among them.
- Examples of different monomers suitable for improving mechanical properties such as flexibility and kink resistance are (meth) acrylic acid alkyl esters, preferably (meth) acrylic acid having an alkyl group having 1 to 20 carbon atoms. Specific examples thereof include methyl (meth) acrylate, ethyl (meth) acrylate, n-propyl (meth) acrylate, n-butyl (meth) acrylate, tert-butyl (meth) acrylate, isobutyl (meth) ) Acrylate, n-hexyl (meth) acrylate, n-octyl (meth) acrylate, 2-ethylhexyl (meth) acrylate, n-heptyl (meth) acrylate, n-nonyl (meth) acrylate, n-decyl (meth) acrylate , Isodecyl (meth) acrylate, n-lauryl
- (Meth) acrylate, n-octyl (meth) acrylate, n-lauryl (meth) acrylate, and n-stearyl (meth) acrylate are more preferred.
- the monomers described below can be copolymerized as desired.
- Examples of the monomer for improving mechanical properties include aromatic vinyl compounds such as styrene, tert-butyl styrene, and ⁇ -methyl styrene.
- Monomers for improving dimensional stability include, for example, ethylene glycol dimethacrylate, diethylene glycol dimethacrylate, triethylene glycol dimethacrylate, polyethylene glycol dimethacrylate, trimethylolpropane trimethacrylate, pentaerythritol tetramethacrylate, bisphenol dimethacrylate, vinyl.
- examples thereof include methacrylate, acrylic methacrylate and acrylates corresponding to these methacrylates, divinylbenzene, triallyl isocyanurate, and the like.
- the preferred amount of the different monomer used is 0.001 to 400 parts by weight, more preferably 0.01 to 300 parts by weight, still more preferably 0.01 to 200 parts by weight, most preferably 100 parts by weight of the silicone monomer. 0.01 to 30 parts by weight.
- the amount of different monomers used is too small, it is difficult to obtain the effect expected of different monomers.
- the amount of different monomers used is too large, mechanical properties such as kink resistance tend to be insufficient.
- the above-mentioned coating material may further contain components such as a pigment, a colorant, a wetting agent, a slip agent, a medicine and a nutritional supplement component, a compatibilizing component, an antibacterial component, and a release agent.
- a pigment such as a pigment, a colorant, a wetting agent, a slip agent, a medicine and a nutritional supplement component, a compatibilizing component, an antibacterial component, and a release agent.
- a colorant such as a pigment, a colorant, a wetting agent, a slip agent, a medicine and a nutritional supplement component, a compatibilizing component, an antibacterial component, and a release agent.
- any component contained in the above-described coating material can be contained in a non-reactive form or a copolymer form with respect to the copolymer.
- the above components are copolymerized, that is, when a colorant having a polymerizable group is used, the component is copolymerized and immobilized with a silicone monomer and a polymerizable monomer having a fluoroalkyl group. This is preferable because the possibility is reduced.
- a thermal polymerization initiator or a photopolymerization initiator typified by a peroxide or an azo compound in order to facilitate the polymerization.
- thermal polymerization those having optimum decomposition characteristics at a desired reaction temperature are selected.
- azo initiators and peroxide initiators having a 10-hour half-life temperature of 40 to 120 ° C. are suitable.
- the photoinitiator for performing photopolymerization include carbonyl compounds, peroxides, azo compounds, sulfur compounds, halogen compounds, and metal salts. These polymerization initiators are used alone or in combination.
- the amount of the polymerization initiator is preferably up to 5% by weight based on the polymerization mixture.
- a polymerization solvent can be used.
- Various organic and inorganic solvents can be used as the solvent.
- solvents include water; methyl alcohol, ethyl alcohol, normal propyl alcohol, isopropyl alcohol, normal butyl alcohol, isobutyl alcohol, t-butyl alcohol, t-amyl alcohol, tetrahydrolinalol, ethylene glycol, diethylene glycol, triethylene glycol, Alcohol solvents such as tetraethylene glycol and polyethylene glycol; methyl cellosolve, ethyl cellosolve, isopropyl cellosolve, butyl cellosolve, propylene glycol monomethyl ether, diethylene glycol monomethyl ether, triethylene glycol monomethyl ether, polyethylene glycol monomethyl ether, ethylene glycol dimethyl ether, diethylene glycol dimethyl ether Glycol ether solvents such as ether, triethylene glycol dimethyl ether and polyethylene glycol dimethyl ether;
- the thickness of the covering material included in the cylindrical structure is preferably 1000 ⁇ m or less, more preferably 800 ⁇ m or less, and most preferably 600 ⁇ m or less.
- the portion of the copolymer exposed on the surface of the covering material of the cylindrical structure has a carboxyl group or a hydroxyl group.
- the method of introducing a carboxyl group or a hydroxyl group into the copolymer to form a copolymer having a carboxyl group or a hydroxyl group is not particularly limited, but the copolymer present on the surface of the coating material is hydrolyzed by surface treatment. Is achieved. Examples of the hydrolysis method include acid treatment, alkali treatment, and plasma treatment, but alkali treatment is preferable from the viewpoint of reaction cost and experimental equipment.
- the (meth) acryloyl acid alkyl ester bond and the siloxane bond of the copolymer existing on the surface of the coating material are hydrolyzed, so that a carboxyl group or It becomes a copolymer containing a hydroxyl group.
- the copolymer of the portion exposed on the surface of the covering material of the above cylindrical structure has a carboxyl group or a hydroxyl group, it hydrates and swells in the body, thereby causing needle stick.
- a hole generated when puncturing with a member can be sealed.
- the copolymer may include at least a part of the structure represented by the following formula (III).
- the copolymer preferably has a carboxyl group or a hydroxyl group.
- R 9 represents hydrogen or a methyl group
- L 3 represents a monovalent group.
- L 3 is preferably a functional group selected from the group consisting of groups represented by the following formulas (LE13) to (LE15).
- R 1 to R 8 each independently represents one or more functional groups selected from the group consisting of hydrogen, an alkyl group having 1 to 20 carbon atoms, a phenyl group, and a fluoroalkyl group having 1 to 20 carbon atoms.
- L 1 and L 2 each independently represent a divalent group, and m and n each independently represents an integer of 0 to 1500. However, m and n are not 0 at the same time. ]
- the group represented by the formula (LE13) may form a salt with a metal such as lithium, sodium, potassium and magnesium.
- Preferred examples of R 1 to R 8 in the groups represented by the above formulas (LE14) to (LE15) are hydrogen; methyl group, ethyl group, propyl group, isopropyl group, butyl group, t- Alkyl groups having 1 to 20 carbon atoms such as butyl group, decyl group, dodecyl group and octadecyl group; phenyl group, trifluoromethyl group, trifluoroethyl group, trifluoropropyl group, tetrafluoropropyl group, hexafluoroisopropyl group, Pentafluorobutyl group, heptafluoropentyl group, nonafluorohexyl group, hexafluorobutyl group, heptafluorobutyl group, oct
- L 1 and L 2 are preferably groups represented by the above formulas (LE1) to (LE12), and above all, represented by the above formulas (LE1), (LE3), (LE5), (LE9) and (LE11).
- the group represented by the above formulas (LE1), (LE3), and (LE5) is more preferred, and the group represented by the following formula (LE1) is most preferred.
- the groups represented by the above formulas (LE1) to (LE12) are drawn on the right side as the terminal bonded to the silicon atom.
- M and n each independently represent the number of each repeating unit.
- m and n each independently preferably ranges from 0 to 1500.
- the total value of m and n (m + n) is preferably 80 or more, more preferably 100 or more, more preferably 100 to 1400, more preferably 120 to 950, and still more preferably 130 to 700.
- the alkali treatment described below is a method in which the above cylindrical structure is immersed in a 0.01 to 10 M aqueous alkali solution and the coating material is subjected to a surface treatment.
- a method such as immersing in a base solution such as sodium hydroxide, potassium hydroxide or ammonia.
- the solution used for the acid treatment and alkali treatment may contain a water-soluble organic solvent such as alcohol.
- ATR single reflection infrared spectroscopy
- ATR single reflection infrared spectroscopy
- C The absorbance at 1740 to 1780 cm ⁇ 1 of the O stretching vibration and the absorbance at 1430 to 1470 cm ⁇ 1 based on the C—H bending vibration derived from the alkyl group can be read.
- the ester group of the copolymer existing on the surface of the coating material is hydrolyzed to generate a carboxyl group, and the absorbance at 1740 to 1780 cm ⁇ 1 derived from the ester decreases.
- the absorbance at 1430 to 1470 cm ⁇ 1 based on C—H bending vibration derived from an alkyl group does not cause hydrolysis even after the alkali surface treatment, and the absorbance does not decrease.
- 1740 is divided by the absorbance I 2 of ⁇ 1780 cm -1 absorbance I 1 to 1430 ⁇ 1470 cm -1, ester group / alkyl group of the copolymer present on the surface of the coating material after the alkali surface treatment
- the absorbance ratio I 1 / I 2 can be determined.
- I 1 / I 2 preferably satisfies the following formula 1.
- I 1 / I 2 is preferably 5.0 or less, more preferably 4.0 or less, and most preferably 3.31 or less.
- I 2 represents the absorbance of the C-H based on deformation vibration 1430 ⁇ 1470 cm -1 .
- the above-described cylindrical structure is configured by covering a cylindrical base material to be described later with the above-described coating material.
- the covering material may cover either the outer surface or the inner surface of the cylindrical base material, but when utilizing the surface properties of the base material on the inner surface, it is preferable to cover only the outer surface, When utilizing the surface properties of the substrate, it is preferable to coat only the inner surface.
- a known method can be used. For example, after obtaining a round bar or a plate-like polymer, a method of processing it into a desired shape by cutting or the like, a mold polymerization method, a spin cast polymerization method, or the like can be used.
- a round bar is inserted into a cylindrical base material, a base material with a round bar inserted is put into a cylindrical mold, one outlet of the mold is sealed with a rubber stopper, and the mold is inserted from the other outlet.
- a monomer mixed solution is injected into the gap between the inner wall and the substrate.
- polymerizing the injected monomer raw material by irradiating active rays, such as an ultraviolet-ray, visible light, or these combination, or heating in oven, a liquid tank, etc. can be considered.
- active rays such as an ultraviolet-ray, visible light, or these combination, or heating in oven, a liquid tank, etc.
- photopolymerization can also be performed after heat polymerization or after heat polymerization.
- a specific method of photopolymerization for example, light containing ultraviolet light such as light from a mercury lamp or ultraviolet lamp (for example, FL15BL (Toshiba)) is applied to the monomer mixed solution in a short time (usually 1 hour or less).
- a method of irradiation for example, FL15BL (Toshiba)
- thermal polymerization a condition in which the temperature of the monomer mixed solution is gradually raised from around room temperature and is raised to a temperature of 60 ° C. to 200 ° C. over several hours or several tens of hours can be reproducible. Preferred to enhance.
- the material used for the cylindrical mold is not particularly limited, and examples thereof include glass, polyethylene, polypropylene, polytetrafluoroethylene, polystyrene, and stainless steel. Among these, glass, polyethylene, and polypropylene are more preferable, and polypropylene is most preferable from the viewpoint of having photopolymerizable transparency and chemical resistance.
- Examples of the round bar inserted into the cylindrical base material include polyethylene, prepropylene, polytetrafluoroethylene, and stainless steel. Among these, from the viewpoint of durability and chemical resistance, polytetrafluoroethylene, polypropylene, and stainless steel materials are more preferable, and stainless steel materials are most preferable.
- a step of removing residual monomer and polymerization solvent may be included by passing through a step of immersing in alcohol and heating to a temperature of 50 to 120 ° C.
- the alcohol to be used include methyl alcohol, ethyl alcohol, normal propyl alcohol, isopropyl alcohol, normal butyl alcohol, isobutyl alcohol, t-butyl alcohol and ethylene glycol.
- methyl alcohol, ethyl alcohol, normal propyl alcohol and isopropyl alcohol are more preferable, and isopropyl alcohol is most preferable from the viewpoint of easy removal by vacuum drying.
- these solvents may be used alone or in combination of two or more.
- the temperature for immersing in alcohol and heating is more preferably 60 to 100 ° C, and most preferably 70 to 90 ° C.
- Examples of the material used for the cylindrical base material used in the cylindrical structure include polyester, polytetrafluoroethylene, and polyurethane.
- polytetrafluoroethylene or polyester is preferable from the viewpoints of flexibility, kink resistance, and stretchability, and polyester is particularly preferable from the viewpoint of biocompatibility.
- the base material used for the above cylindrical structure is a cylindrical woven fabric woven by crossing warps and wefts, and is not subjected to crimping as usual. Therefore, the difference in the outer diameter in the warp direction of the tubular fabric can be made within 10%.
- the above "difference in outer diameter is within 10%" means that five points are measured at intervals of 50 mm in the warp direction, the maximum value and the minimum value are evaluated, the minimum value is subtracted from the maximum value, and the maximum value The value expressed as a percentage by dividing by “outer diameter difference”.
- the value of (L2-L1) / L1 is preferably 0.15 or more, more preferably 0.18 or more, from the viewpoint that the stretchability and flexibility can be further improved.
- the upper limit is preferably 1.0.
- a stretching operation or a compressing operation with a stress of 0.01 cN / dtex usually corresponds to a stress when a person stretches and compresses the tubular fabric lightly in the warp direction by hand, and when it is within the above range, This means that the operability is good even when the bending operation is performed by hand, and that it has excellent elasticity and flexibility.
- the elongation is 30% or less. This is preferable because it is easy to feel a response. More preferably, it is 20% or less, more preferably about 10%. Further, the lower limit is preferably 5% or more, and more preferably 8% or more from the viewpoint that a feeling of elongation can be felt when a person pulls lightly by hand.
- the minimum outer diameter b of the woven fabric preferably satisfies the following formula 3.
- the value of (ab) / a is defined as a variation index c
- the inner diameter difference of the tubular fabric Becomes smaller, and a flow path without change can be secured.
- corrugation of the inner surface of a cylindrical fabric is 100 micrometers or less, More preferably, it is 80 micrometers or less, More preferably, it is 60 micrometers or less.
- the lower limit is preferably 3 ⁇ m or more from the viewpoint of endothelium formation when used as an artificial blood vessel.
- a cylindrical fabric does not have a bellows structure.
- no irregularities on the inner surface there is no irregularities on the inner surface, and no turbulent flow occurs even when fluid flows between thin, especially when used for thin artificial blood vessels, there is no turbulent flow in the blood flow, and thrombus
- “No bellows structure” means that a mandrel having a spiral or annular corrugated groove is inserted into a cylindrical fabric, and the fabric is not subjected to corrugated set processing by heating or is not pleated Say.
- Synthetic fibers are preferably used for the warp and weft of the cylindrical woven fabric used in the above-described cylindrical structure, and specific examples include nylon fibers or polyester fibers, but so-called inelastic yarns are used. More preferred.
- “Non-elastic yarn” is a fiber that does not have so-called rubber elasticity, and is a material excellent in extensibility and recoverability, such as a thermoplastic elastomer represented by polyether elastomer, polysulfide elastomer, polyurethane elastomer, etc. It is a fiber different from a fiber having rubber elasticity, so-called elastic yarn.
- the fiber used for said cylindrical textile fabric has a polyester fiber of an inelastic thread
- inelastic yarn polyester fibers include fibers made of polyethylene terephthalate, polybutylene terephthalate, polypropylene terephthalate, and copolymers thereof.
- the cylindrical woven fabric used for the above cylindrical structure has elasticity in itself. Therefore, an elastic yarn may be used, and a woven fabric may be manufactured using an inelastic yarn.
- the cylindrical woven fabric can be manufactured as follows, for example.
- warp A and warp B are also preferably inelastic yarns as described above.
- the warp A can be composed of various synthetic fibers such as nylon fibers or polyester fibers. Of these, non-elastic polyester fibers are preferred in terms of strength and dimensional stability.
- inelastic yarn polyester fibers include fibers made of polyethylene terephthalate, polybutylene terephthalate, polypropylene terephthalate, and copolymers thereof.
- the warp A constituting the woven fabric may be an ultrafine fiber that is directly spun, or may be an ultrafine fiber obtained by removing sea-island composite fibers.
- a part or all of the single yarn diameter of the synthetic fiber in the warp direction is a multifilament of 5 ⁇ m or less.
- the warp B is preferably composed of dissolved yarn.
- the dissolved yarn is a fiber that is soluble in a solvent such as water or an alkaline solution.
- a solvent such as water or an alkaline solution.
- Specific examples of the dissolved yarn include water-soluble fibers such as polyvinyl alcohol fibers, isophthalic acid, and 5-sodium sulfoisophthalic acid.
- a readily alkali-soluble fiber such as a polyester fiber or a polylactic acid fiber in which a third component such as methoxypolyoxyethylene glycol is copolymerized can be used, but it is not particularly limited.
- the temporary yarn removed after weaving can also be used as the warp B.
- the total fineness of each warp is preferably 560 dtex or less, more preferably 235 dtex or less, more preferably 100 dtex or less.
- the weaving density of the warp A after post-processing is preferably 300 pieces / inch (2.54 cm) or less, more preferably 280 pieces / inch (2.54 cm) or less, more preferably 250 pieces / inch (2.54 cm).
- weft C and weft D weft C and weft D
- a cylindrical fabric having a two-layer structure A preferred embodiment in this case is a case where the weft C is located in the inner layer of the tubular fabric and the weft D is located in the outer layer of the tubular fabric.
- the weft C located in the inner layer and the weft D located in the outer layer can be composed of various synthetic fibers such as nylon fibers or polyester fibers, but are preferably inelastic yarns. Of these, non-elastic polyester fibers are preferred in terms of strength and dimensional stability. Examples of inelastic yarn polyester fibers include fibers made of polyethylene terephthalate, polybutylene terephthalate, or polypropylene terephthalate.
- the weft C located in the inner layer is preferably an ultrafine fiber obtained by using a sea-island composite fiber or a directly spun ultrafine fiber as a raw yarn, after the sea-island composite fiber is desealed or directly spun.
- a part or all of the single yarn diameter of the weft C is 5 ⁇ m or less.
- the single yarn diameter of the weft D located in the outer layer is preferably 10 ⁇ m to 20 ⁇ m. By setting the single yarn diameter within the above range, the rigidity of the inner layer is improved, deterioration due to hydrolysis can be suppressed, and durability can be improved.
- the total fineness of each weft is preferably 560 dtex or less, more preferably 235 dtex or less, more preferably 100 dtex or less.
- the weave density of each weft after post-processing is preferably 200 pieces / inch (2.54 cm) or less, more preferably 180 pieces / inch (2.54 cm) or less, more preferably 150 pieces / inch (2.54 cm).
- the warp B is woven with a high tension and the warp A is woven with a low tension within a range that does not hinder the opening.
- the warp B preferably has a tension of 0.5 to 1.5 cN / dtex
- the warp A preferably has a tension of 0.05 to 0.15 cN / dtex.
- the warp A and the warp B are preferably arranged at a ratio of 1 warp B to 2 to 10 warps A. In general, if the warp tension is lowered during weaving in order to increase the crimp ratio of the warp in a high-density woven fabric, it is difficult to increase the weft density by bumping (weft unwinding).
- the weft can be restrained by the warp A with the warp B as a fulcrum, and bumping can be suppressed. Therefore, the crimp rate of the warp A can be increased, and flexibility can be imparted to the tubular woven fabric by removing the warp B after weaving. Furthermore, the warp B is preferably disposed between the weft C located in the inner layer and the weft D located in the outer layer. In addition, the use of at least two kinds of wefts C, which are located in the inner layer of the tubular fabric, and the weft D, located in the outer layer, causes structural distortion due to the difference in the peripheral length between the weft C and the weft D. . Thereby, extensibility can be provided to a cylindrical fabric.
- the inner diameter of the cylindrical woven fabric is preferably 100 mm or less, more preferably 50 mm or less, more preferably 10 mm or less.
- a preferable lower limit is about 1.5 mm from the viewpoint of weaving.
- the post-processing step is preferably performed through the following steps, for example.
- the case where the internal diameter of a cylindrical fabric is 3 mm is illustrated.
- the raw thread oil agent is dropped and the warp B is contracted by hot water washing.
- the treatment conditions are preferably a temperature of 80 to 98 ° C. and a time of 15 to 40 minutes.
- Pre-heat set stabilizes the shape of the warp A in which the crimp rate has increased as the warp B contracts.
- a round bar having an outer diameter of 2.8 mm is inserted into a cylindrical woven fabric, and both ends are fixed with a wire or the like to perform heat treatment.
- the treatment conditions are preferably a temperature of 160 to 190 ° C. and a time of 3 to 10 minutes.
- the material of the said round bar can mention stainless steel material, for example.
- (C-1) Acid treatment The sea component of the sea-island composite fiber is embrittled by acid treatment.
- the acid include maleic acid.
- the treatment conditions are preferably a concentration of 0.1 to 1% by weight, a temperature of 100 to 150 ° C., and a time of 10 to 50 minutes. When sea-island composite fibers are not used, acid treatment can be omitted.
- (C-2) Alkali treatment The sea component of the sea-island composite fiber embrittled by the dissolved yarn and the acid treatment is eluted by alkali treatment.
- alkali include sodium hydroxide.
- the treatment conditions are preferably a concentration of 0.5 to 2% by weight, a temperature of 70 to 98 ° C., and a time of 60 to 100 minutes.
- (D) Heat setting (first time) The purpose is to maximize again the crimp of the warp that has been loosened by the sea removal treatment by the first heat setting.
- a round bar having an outer diameter of 3 mm is inserted into a cylindrical woven fabric and heat-treated by fixing both ends with a wire or the like in a state compressed to the maximum in the warp direction so as not to cause wrinkles.
- the treatment conditions are preferably a temperature of 160 to 190 ° C. and a time of 3 to 10 minutes.
- the material of a round bar can mention stainless steel material, for example.
- the second heat setting is intended to make a woven fabric having a shrinkage allowance while leaving the bending point of the crimp, but the second time may not be performed.
- a round bar having an outer diameter of 3 mm is inserted into a tubular woven fabric, heat-treated by fixing both ends with a wire or the like in a state of being stretched by 20 to 50% in the warp direction.
- the treatment conditions are a temperature lower by 10 to 20 ° C. than the first heat setting, and a time of 3 to 10 minutes is preferable.
- the material of the said round bar can mention stainless steel material, for example.
- the cylindrical woven fabric thus obtained is a cylindrical woven fabric having small irregularities on the inner surface and excellent stretchability, flexibility and kink resistance (flexibility).
- the antithrombogenicity is a property that blood does not coagulate on the surface in contact with blood, and inhibits blood coagulation that progresses by, for example, platelet aggregation and activation of blood coagulation factors represented by thrombin. It is a property to do.
- the method of forming the antithrombotic surface is not particularly limited, and after modifying the inner surface of the cylindrical substrate, heparin or a heparin derivative is covalently bonded to the inner surface of the cylindrical substrate (special table) 2009-545333, Patent No.
- Patent No. 3497612 a method of ion-bonding heparin or a heparin derivative to the inner surface of a cylindrical base material, or a gel such as collagen or gelatin.
- a method of applying heparin or a heparin derivative Japanese Patent No. 3799626 and Japanese Patent Publication No.
- the antithrombotic material is preferably a compound having anticoagulant activity.
- the compound having anticoagulant activity may be a compound having a property of inhibiting blood coagulation that proceeds by platelet aggregation or activation of a blood coagulation factor represented by thrombin.
- clopidogrel sulfate Salt prasugrel sulfate, ticlopidine hydrochloride, dipyridamole, cilostazol, beraprost sodium, limaprost alfadex, ozagrel sodium, sarpogrelate hydrochloride, ethyl icosapentate, trapidil, warfarin potassium, heparin sodium, heparin potassium, dalteparin sodium, parnaparin sodium, levapirin Sodium, rivaroxaban, apixaban, endoxaban, dabigatran, argatroban, dextran sulfate, polyvinyl sulfonic acid, polystyrene sulfonic acid, etc.
- an anionic anticoagulant compound As the compound having anticoagulant activity, it is preferable to contain a cationic polymer in addition to the compound having anticoagulant activity.
- a cationic polymer in addition to the compound having anticoagulant activity.
- alkyleneimine, vinylamine More preferably, it contains a cationic polymer containing as a monomer unit a compound selected from the group consisting of allylamine, lysine, protamine and diallyldimethylammonium chloride.
- the polymer Since these monomer units have a cationic nitrogen atom, the polymer becomes cationic, whereas the compound containing a sulfur atom having anticoagulant activity is anionic, so that both of them are ionically bonded. Can do.
- the anionic anticoagulant compound containing a sulfur atom include heparin, heparin derivatives, dextran sulfate, polyvinyl sulfonic acid and polystyrene sulfonic acid, and heparin or heparin derivatives are more preferable. Heparin or a heparin derivative may be purified or not, and is not particularly limited as long as it can inhibit the blood coagulation reaction.
- Heparin generally used in clinical practice In addition to unfractionated heparin and low molecular weight heparin, high affinity heparin is also included in antithrombin III. Specific examples of heparin include “heparin sodium” (Organon API).
- the cationic polymer Since the cationic polymer has a cationic property and may develop hemolytic toxicity, it is not preferable to elute it in the blood. Therefore, the cationic polymer is preferably chemically bonded to the inside of the cylindrical base material, and more preferably covalently bonded.
- the covalent bond refers to a chemical bond generated by sharing electrons between atoms.
- the polymer constituting the antithrombogenic material and the surface of the base material are covalent bonds between atoms such as carbon, nitrogen, oxygen, sulfur, etc., and even a single bond is a multiple bond. It does not matter.
- the kind of covalent bond is not limited, For example, an amine bond, an azide bond, an amide bond, an imine bond, etc. are mentioned. Among these, an amide bond is more preferable from the viewpoint of easy formation of a covalent bond and stability after bonding.
- the cationic polymer may be a homopolymer or a copolymer.
- the cationic polymer when it is a copolymer, it may be a random copolymer, a block copolymer, a graft copolymer or an alternating copolymer, but the repeating unit containing a nitrogen atom is continuous.
- a block copolymer is more preferable because the block portion and a compound having an anionic anticoagulant activity containing a sulfur atom interact to form a strong ionic bond.
- the homopolymer refers to a polymer compound obtained by polymerizing one type of monomer unit
- the copolymer refers to a polymer compound obtained by copolymerization of two or more types of monomers.
- the block copolymer is a copolymer having a molecular structure in which at least two kinds of polymers having different repeating units are connected by covalent bonds to form a long chain.
- a block constitutes a block copolymer. Each of at least two kinds of polymers having different repeating units.
- the structure of the cationic polymer may be linear or branched.
- a branched structure is more preferable because it can form more stable ionic bonds at multiple points with an anionic anticoagulant compound containing a sulfur atom.
- the cationic polymer has at least one functional group among primary to tertiary amino groups and quaternary ammonium groups.
- the group has a stronger ionic interaction with an anionic anticoagulant compound containing a sulfur atom than a primary to tertiary amino group, and has an anionic anticoagulant activity containing a sulfur atom. This is preferable because the elution rate of the compound is easily controlled.
- the number of carbon atoms of the three alkyl groups constituting the quaternary ammonium group is not particularly limited. However, the quaternary ammonium is not excessively increased in hydrophobicity and steric hindrance. A compound having an anionic anticoagulant activity that effectively contains a sulfur atom in the group is easily ionically bonded.
- the number of carbon atoms per alkyl group bonded to the nitrogen atom constituting the quaternary ammonium group is preferably 1 to 12, and more preferably 2 to 6.
- the three alkyl groups bonded to the nitrogen atom constituting the quaternary ammonium group may all have the same carbon number or may be different.
- polyalkyleneimine as the cationic polymer because of the large amount of adsorption based on the anionic anticoagulant activity compound containing sulfur atom and ionic interaction.
- the polyalkyleneimine include polyethyleneimine (hereinafter referred to as “PEI”), polypropyleneimine and polybutyleneimine, and further alkoxylated polyalkyleneimine, and PEI is most preferable among them.
- PEI examples include “LUPASOL (registered trademark)” (manufactured by BASF) and “EPOMIN (registered trademark)” (manufactured by Nippon Shokubai Co., Ltd.). Copolymers with other monomers may be used as long as they do not interfere with the above, and PEI may be a modified product.
- the modified body refers to a monomer in which the repeating unit of the monomer constituting the cationic polymer is the same, for example, a part of which undergoes radical decomposition, recombination, etc. by irradiation with radiation described below. .
- the weight average molecular weight of the cationic polymer is preferably from 600 to 2,000,000, more preferably from 1,000 to 1500,000, and even more preferably from 10,000 to 1,000,000.
- the weight average molecular weight of the cationic polymer can be measured by, for example, a gel permeation chromatography method or a light scattering method.
- the manufacturing method of the antithrombotic material is shown below.
- a solution containing a compound having an anionic anticoagulant activity containing an atom may be coated by immersing the target substrate, but has an anionic anticoagulant activity containing the polymer and a sulfur atom.
- the inner surface of the base material may be coated with an antithrombotic material after all or any of the compounds have been reacted in advance between the compounds, and a layer of the antithrombogenic material may be formed on the inner surface of the base material. .
- the first antithrombogenic material coating step from the group consisting of alkyleneimine, vinylamine, allylamine, lysine, protamine and diallyldimethylammonium chloride.
- the anionic anticoagulant compound containing a sulfur atom is added to the cation as the second antithrombogenic material coating step.
- a method of ion-bonding to the conductive polymer is more preferable.
- a step of quaternizing the cationic polymer may be added after the first antithrombogenic material coating step.
- a cationic polymer containing a compound selected from the group consisting of alkyleneimine, vinylamine, allylamine, lysine, protamine and diallyldimethylammonium chloride as a monomer unit is covalently bonded to the inner surface of the substrate. Then, a manufacturing method in the case of using a method of ion-bonding a compound having an anionic anticoagulant activity containing a sulfur atom to the cationic polymer as a second antithrombogenic material coating step will be described below.
- the method for covalently bonding the cationic polymer to the inner surface of the substrate is not particularly limited, but the substrate is a functional group (hydroxyl group, thiol group, amino group, carboxyl group, aldehyde group, isocyanate group, thioisocyanate, etc. ), There is a method of covalently bonding with a cationic polymer by a chemical reaction.
- a polymer having a hydroxyl group, a thiol group, an amino group or the like may be covalently bonded to the inner surface of the substrate, or a compound having a hydroxyl group, a thiol group, an amino group, or the like And a method of covalently bonding to the inner surface of a substrate having a carboxyl group and the like.
- the substrate does not have a functional group
- a method of covalently bonding a cationic polymer, or irradiation with radiation the inner surface of the substrate and the cationic
- the inner surface of the substrate and the cationic There is a method of generating radicals in a polymer and covalently bonding the inner surface of the substrate and the cationic polymer by a recombination reaction.
- radiation ⁇ rays and electron beams are mainly used.
- the amount of ⁇ rays is preferably 2.5 million to 10 million Ci, and more preferably 3 million to 7.5 million Ci.
- the acceleration voltage of the electron beam is preferably 5 MeV or more, and more preferably 10 MeV or more.
- the radiation dose is preferably 1 to 50 kGy, more preferably 5 to 35 kGy.
- the irradiation temperature is preferably 10 to 60 ° C, more preferably 20 to 50 ° C.
- an antioxidant may be used to control the amount of radicals generated.
- the term “antioxidant” refers to a molecule that has the property of easily giving electrons to other molecules. Antioxidants to be used are not particularly limited.
- water-soluble vitamins such as vitamin C, polyphenols, alcohols such as methanol, ethanol, propanol, ethylene glycol, propylene glycol and glycerin, glucose and galactose Sugars such as mannose and trehalose, inorganic salts such as sodium hydrosulfite, sodium pyrosulfite, sodium dithionate, uric acid, cysteine, glutathione, bis (2-hydroxyethyl) iminotris (hydroxymethyl) methane (hereinafter referred to as “ Bis-Tris ”) and the like.
- Bis-Tris bis (2-hydroxyethyl) iminotris (hydroxymethyl) methane
- methanol, ethanol, propylene glycol, and Bis-Tris are particularly preferable from the viewpoint of handleability and persistence, and propylene glycol or Bis-Tris is more preferable.
- These antioxidants may be used alone or in combination of two or more. The antioxidant is preferably added to the aqueous solution.
- polyester When polyester is used as the material of the cylindrical base material, it is not particularly limited, but a method of covalently bonding by an aminolysis reaction by contacting a cationic polymer under heating conditions can also be used.
- the ester bond on the inner surface of the substrate can be hydrolyzed by acid and alkali treatment, and the carboxyl group generated on the inner surface of the substrate and the amino group of the cationic polymer can be condensed and covalently bonded.
- the cationic polymer may be brought into contact with the inner surface of the substrate to cause the reaction, but may also be brought into contact with the base while being dissolved in a solvent.
- the monomer constituting the cationic polymer may be polymerized while being in contact with the inner surface of the substrate, and then reacted to be covalently bonded.
- the heating means is not particularly limited, and examples thereof include electric heating, microwave heating, and far infrared heating.
- the heating temperature is preferably near the glass transition point and below the melting point.
- a step of hydrolyzing and oxidizing the ester bond on the inner surface of the substrate having an ester group may be used.
- a method of treating with an acid or alkali and an oxidizing agent is preferably used.
- a method of treating with an acid or alkali and an oxidizing agent is particularly preferably used.
- either a combination of an acid and an oxidizing agent or a combination of an alkali and an oxidizing agent may be used as a treatment method.
- a method of treating with a combination of an acid and an oxidizing agent is preferred.
- the type of acid used is not particularly limited.
- Inorganic acids such as phosphoric acid, hexafluoroantimonic acid, tetrafluoroboric acid, chromic acid and boric acid, methanesulfonic acid, ethanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid, trifluoromethanesulfonic acid and polystyrenesulfone Sulfonic acids such as sodium acid, acetic acid, citric acid, formic acid, gluconic acid, carboxylic acids such as lactic acid, oxalic acid and tartaric acid, vinyl carboxylic acids such as ascorbic acid and meldrum acid, and nucleic acids such as deoxyribonucleic acid and
- the type of base used is not particularly limited.
- alkali metal hydroxides such as lithium hydroxide, sodium hydroxide, potassium hydroxide, rubidium hydroxide and cesium hydroxide, tetramethyl hydroxide Tetraalkylammonium hydroxides such as ammonium and tetraethylammonium hydroxide, hydroxides of alkaline earth metals such as calcium hydroxide, strontium hydroxide, barium hydroxide, europium hydroxide and thallium hydroxide, guanidine compounds, diammines Examples thereof include hydroxides of ammine complexes such as silver (I) hydroxide and tetraammine copper (II) hydroxide, and trimethylsulfonium hydroxide and diphenyliodonium hydroxide.
- lithium hydroxide, sodium hydroxide, potassium hydroxide, and the like are more preferable from the viewpoint of handleability and the like.
- the kind of the oxidizing agent used is not particularly limited, but for example, potassium nitrate, hypochlorous acid, chlorous acid, perchloric acid, halogen such as fluorine, chlorine, bromine and iodine, potassium permanganate, Permanganate such as sodium permanganate trihydrate, ammonium permanganate, silver permanganate, zinc permanganate hexahydrate, magnesium permanganate, calcium permanganate and barium permanganate, nitric acid Examples include peroxides such as cerium ammonium, chromic acid, dichromic acid, and hydrogen peroxide, torence reagents, and sulfur dioxide. Among them, the strength of oxidizing agents and the deterioration of antithrombotic materials can be appropriately prevented. Permanganate is more preferable from the viewpoint of being able to do so.
- a method for covalently bonding a cationic polymer to the inner surface of a cylindrical base material made of polyester for example, there is a method of performing a condensation reaction using a dehydration condensing agent or the like.
- the type of the dehydrating condensing agent to be used is not particularly limited.
- the dehydration condensation agent may be used together with a dehydration condensation accelerator.
- the dehydration condensation accelerator used is not particularly limited, and examples thereof include pyridine, 4-dimethylaminopyridine, triethylamine, isopropylamine, 1-hydroxybenzotriazole, and N-hydroxysuccinimide.
- the cationic polymer, the dehydration condensing agent and the dehydration condensation accelerator may be reacted in the form of a mixed aqueous solution, or may be added and reacted in order.
- the cationic polymer has a primary to tertiary amino group as a functional group, the ion interaction with heparin or a heparin derivative is strengthened, and the elution rate of heparin is easily controlled.
- a step of converting the polymer to quaternary ammonium may be added.
- quaternary ammonium may be formed before the cationic polymer is covalently bonded to the inner surface of the substrate, or the cationic polymer is covalently bonded to the inner surface of the substrate. Although quaternary ammonium may be used later, in order to strengthen the ionic interaction between the cationic polymer and the anionic anticoagulant compound containing a sulfur atom, It is preferable to quaternary ammonium.
- the alkyl halide compound or the glycidyl group-containing quaternary ammonium salt may be directly contacted, or dissolved in an aqueous solution or an organic solvent and contacted. May be.
- the second antithrombotic material coating step for ionically bonding a compound having an anionic anticoagulant activity containing a sulfur atom to the cationic polymer is not particularly limited, but there is a method of contacting in the state of an aqueous solution. preferable.
- the anti-factor Xa activity is an index representing the degree of inhibiting the activity of factor Xa that promotes the conversion of prothrombin to thrombin, and the surface of heparin or heparin derivatives in the active unit in the antithrombotic material. You can know the amount.
- “Test Team (registered trademark) Heparin S” manufactured by Sekisui Medical Co., Ltd. was used.
- the anti-factor Xa activity is too low, the surface amount of heparin or a heparin derivative in the antithrombotic material is small, and the desired antithrombogenicity is difficult to obtain.
- the anti-factor Xa activity is too high, the surface amount of heparin or a heparin derivative is sufficient to express the desired antithrombotic property, but the thickness of the antithrombotic material increases, so The surface fine structure may not be maintained.
- the total coating amount by the anti-factor Xa activity on the surface of the antithrombotic material is preferably 10 mIU / mg or more and 20000 mIU / mg or less per unit weight of the base material, and the total coating amount is 50 mIU / mg or more and 10,000 mIU / mg. More preferably, it is mg.
- the total coating amount here refers to the amount of heparin eluted in normal human plasma after the substrate cut into about 0.5 cm ⁇ 1 cm is immersed in 5 mL of normal human plasma and shaken for 24 hours in an atmosphere of 37 degrees. It is calculated by summing the amount of surface heparin remaining on the surface of the material.
- the coating material of the present invention can cover the above cylindrical structure without impairing the antithrombogenicity of the inner surface by coating only the outer surface of the above cylindrical structure.
- Kink means that when a thread, a rod, or a cylindrical object is gradually bent, it becomes apparent that extreme folding or crushing occurs, making it difficult to return.
- a cylindrical structure is used as an artificial blood vessel, there is a possibility that the occurrence of kinks may immediately lead to occlusion of the blood vessels, so that flexibility that prevents kinks from occurring is required.
- a method of measuring kink resistance there is a method of measuring the minimum kink radius in accordance with the guidance of IS07198.
- the minimum kink radius measured by this method is preferably 15 mm or less, more preferably 12 mm or less, further preferably 8 mm or less, and most preferably 5 mm or less.
- the water leakage is a value obtained by calculating the amount of water leakage per unit time by puncturing a tubular structure filled with water with a puncture member and measuring the weight of water leaking from the inside.
- the water leakage per puncture is preferably 50 g / min or less, more preferably 40 g / min or less, more preferably 20 g / min or less, and more preferably 10 g / min or less. Most preferred.
- Fineness, number of filaments The fineness was measured based on JIS L 1013: 2010 8.3.1 Positive Fineness (Method A). The number of filaments was measured based on JIS L 1013: 2010 8.4.
- FIG. 1 is an explanatory diagram for drawing a marked line on a tubular fabric.
- a first marked line 2 is drawn on the outer periphery of the fabric 5 mm from one end of the tubular fabric 1.
- a second marked line 3 is drawn on the outer periphery of the fabric at a distance A that is five times the maximum value of the outer diameter of the fabric.
- the cylindrical fabric 1 is cut in the radial direction at a position 5 mm from the second marked line.
- FIG. 2 is a conceptual diagram of an apparatus for measuring a distance between marked lines during compression of a cylindrical fabric.
- the apparatus has a handy gauge 4 (HANDY DIGITAL FORCE GAUGE HF-1 (rated capacity 10 N; manufactured by Nihon Keisoku System Co., Ltd.)) installed on the gantry 5 and a core rod.
- a compression chuck jig 6 having a portion is attached to the load measuring instrument 4, and a compression receiving jig 7 having a hole portion into which the core rod portion can be inserted is attached to the mount 5.
- the core rod portion of the compression chuck jig 6 to be inserted into the tubular fabric 1 has a minimum portion of the fabric inner diameter of the tubular fabric 1 of ⁇ 0.1 mm ( ⁇ 0.03 mm).
- the hole diameter of the compression receiving jig 7 is the same diameter as the minimum woven fabric inner diameter portion of the cylindrical woven fabric.
- the same diameter does not need to be exactly the same diameter, and a difference of about ⁇ 0.03 mm is treated as the same diameter.
- FIG. 3 is a conceptual diagram of an apparatus for measuring the distance between the marked lines when the tubular fabric is stretched. As shown in FIG. 3, the apparatus is a load measuring device (force gauge) 4.
- HANDY DIGITAL FORCE GAUGE HF-1 (rated capacity: 10N) manufactured by Japan Measuring System Co., Ltd. is installed on the gantry 5, the extension chuck jig 8 is attached to the load measuring instrument 4, and the extension receiving jig 9 is installed on the gantry 5 is attached.
- the number of punctures corresponding to 8 times / (outer surface area: cm 2 ) is calculated from the outer surface area of the cylindrical structure used, and after puncturing in a long axis direction so as not to overlap the already punctured holes
- the water leakage per 8 times / cm 2 was calculated by the same operation as above.
- Warp A (sea-island composite fiber): polyethylene terephthalate fiber, 66 dtex, 9 filaments (after sea removal treatment: 52.8 dtex, 630 filaments)
- Warp B (dissolved yarn): Easily alkali-soluble polyester fiber copolymerized with 5-sodium sulfoisophthalic acid, 84 dtex, 24 filaments
- Weft C inner layer
- shea-island composite fiber polyethylene terephthalate fiber, 66 dtex, 9 filament (detached) After sea treatment: 52.8 dtex, 630 filament)
- Weft D (outer layer): polyethylene terephthalate fiber, 56 dtex, 18 filaments
- the tension of warp B being 0.9 cN / dtex and the tension of warp A being 0.1 cN / dtex.
- the weaving density of warp A is 201 / inch (2.54 cm)
- the weaving density of weft C is 121 / inch (2.54 cm)
- the weaving density of weft D is 121 / inch (2.54 cm).
- a cylindrical woven fabric having an inner diameter of 3 mm was woven.
- the warp A and the warp B were arranged at a ratio of 1 warp B to 3 warps A. Further, the warp B was disposed between the weft C located in the inner layer and the weft D located in the outer layer.
- post-processing was performed by the following steps.
- (B) Pre-heat set A round bar having an outer diameter of 2.8 mm was inserted into a tubular woven fabric, and both ends were fixed with a wire to perform heat treatment.
- the treatment conditions were a temperature of 180 ° C. and a time of 5 minutes.
- the round bar was made of stainless steel.
- (C-1) Acid treatment Maleic acid was used as the acid.
- the treatment conditions were such that the concentration was 0.2% by weight, the temperature was 130 ° C., and the time was 30 minutes.
- the treatment conditions were a concentration of 1 wt%, a temperature of 80 ° C., and a time of 90 minutes, and the cylindrical fabric was subjected to alkali treatment.
- the sample was immersed in a 1% by weight methanol aqueous solution of ethyl bromide (manufactured by Wako Pure Chemical Industries, Ltd.), reacted at 35 ° C. for 1 hour, heated to 50 ° C. and reacted for 4 hours.
- the PEI covalently bonded to the inner surface of the obtained cylindrical fabric was quaternized ammonium.
- Example 1 A stainless steel material round bar 6 cm in diameter of 3 mm is inserted into the cylindrical fabric 5 cm obtained in Reference Example 1, and a stainless steel material made of polypropylene having a diameter of 6 mm, an inner diameter of 4.5 mm, and a length of 6 cm.
- a cylindrical woven fabric with a round bar inserted was put, and one outlet of the mold was sealed with a rubber stopper. From the other outlet, the prepared monomer mixture solution is poured into the gap between the cylindrical mold and the cylindrical fabric until the cylindrical fabric is completely immersed, and a fluorescent lamp (Toshiba, FL-6D, daylight, 6W, 4) and polymerized by light irradiation (1.01 mW / cm 2, 20 minutes).
- a fluorescent lamp Toshiba, FL-6D, daylight, 6W, 4
- the mold was immersed in isopropyl alcohol and heated at 80 ° C. for 1 hour, and then the cylindrical structure obtained from the mold was taken out and peeled off together with a round bar made of stainless steel. Further, after being immersed in isopropyl alcohol at room temperature for 30 minutes, the stainless steel rod was removed from the cylindrical structure and allowed to air dry overnight.
- Table 2 shows the results of the kink radius, water leakage, and absorbance ratio I 1 / I 2 of the obtained cylindrical structure.
- Example 2 Alkaline treatment liquid prepared by the same operation as in Example 1 and having a tubular fabric coated with a copolymer prepared in an aqueous solution with an ethanol concentration of 10 v / v% so as to have a sodium hydroxide concentration of 4.0 mol / L.
- the reaction treatment time was 1 hour at 60 ° C. After the reaction, the cylindrical structure was taken out from the treatment liquid, washed 3 times with RO water, and then air-dried overnight.
- Table 2 shows the results of the kink radius, water leakage, and absorbance ratio I 1 / I 2 of the obtained cylindrical structure.
- Example 3 The sodium hydroxide concentration and the reaction treatment time in the alkaline treatment liquid were respectively set to Example 3 (sodium hydroxide concentration was 2.0 mol / L; reaction treatment time was 1 hour), and Example 4 (sodium hydroxide concentration was 1.
- Example 5 sodium hydroxide concentration 0.5 mol / L; reaction treatment time 6 hours
- Example 6 sodium hydroxide concentration 0.25 mol / L; Reaction treatment time 6 hours
- Example 7 sodium hydroxide concentration 0.125 mol / L; reaction treatment time 6 hours
- Example 8 sodium hydroxide concentration 0.05 mol / L; reaction treatment time 6 hours
- Example 9 the sodium hydroxide concentration was 0.01 mol / L; the reaction treatment time was 6 hours
- Example 2 Five layers of a dressing tape (waterproof film roll; manufactured by Kyowa Co., Ltd.) made of only polyurethane and having a film thickness of 20 ⁇ m was wound on 5 cm of a cylindrical fabric obtained by the same operation as in Reference Example 1. Thereby, the cylindrical structure which coat
- a dressing tape waterproof film roll; manufactured by Kyowa Co., Ltd.
- Comparative Example 4 An artificial blood vessel (Gore-Tex (registered trademark); manufactured by Gore) consisting of ePTFE and having a length of 5 cm, an inner diameter of 3 mm, and a thickness of 0.5 mm was prepared and used as Comparative Example 4. Table 2 shows the kink radius and water leakage results.
- Gore-Tex registered trademark
- Table 2 shows the kink radius and water leakage results.
- Example 10 The copolymer was coated by the same operation as in Example 1 using an artificial blood vessel made only of ePTFE prepared in Comparative Example 4 as a base material.
- Table 2 shows the kink radius and water leakage results of the obtained cylindrical structure.
- Comparative Example 5 Using the artificial blood vessel consisting only of ePTFE prepared in Comparative Example 4 as a base material, the base material is coated with silicone by the same operation as Comparative Example 1, and a cylindrical structure in which the ePTFE base material is coated with silicone is obtained. Used as Comparative Example 5 of the following test. Table 2 shows the kink radius and water leakage results of the obtained cylindrical structure.
- Comparative Example 6 By using an artificial blood vessel composed only of ePTFE prepared in Comparative Example 4 as a base material and winding a urethane dressing tape by the same operation as in Comparative Example 2, a tubular structure in which the ePTFE base material is coated with urethane tape is obtained. Obtained and used as Comparative Example 6 of the following test. Table 2 shows the kink radius and water leakage results of the obtained cylindrical structure.
- Comparative Example 7 An artificial blood vessel made of only polyurethane and having a length of 5 cm, an inner diameter of 6 mm, and a thickness of 1.0 mm (Solatech (registered trademark); manufactured by Goodman Corporation) was prepared and used as Comparative Example 7 in the following test. Table 2 shows the kink radius and water leakage results.
- Comparative Example 8 An artificial blood vessel (Gracil (registered trademark); manufactured by Terumo Corporation) having a length of 5 cm, an inner diameter of 5.6 mm, and a thickness of 1.2 mm made of a three-layer structure of polyester, styrene elastomer and polyolefin is prepared. Used as Comparative Example 8. Table 2 shows the kink radius and water leakage results.
- the above-mentioned cylindrical structure can be usefully used for fluid, powder transfer hose and linear object protection hose, cylindrical filter, artificial blood vessel base material and the like.
- it can be suitably used as a medical tube that can be implanted in a living body, and since it has kink resistance, it is suitable for an artificial blood vessel, and since water leakage after puncture is low, It can be particularly suitably used for dialysis shunts that require repeated puncturing.
- Cylindrical woven fabric ... 1, first marked line ... 2, second marked line ... 3, load measuring instrument ... 4, gantry ... 5, compression chuck jig ... ⁇ 6, receiving jig for compression ... 7, chuck jig for extension ... 8, receiving jig for extension ... 9, fixed string ... 10, 5 times the maximum value of the outer diameter of the fabric Marking distance ...
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Textile Engineering (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Abstract
Description
(1) 筒状の基材と、上記基材を被覆する被覆材と、を備え、上記被覆材は、シリコーンモノマー及びフルオロアルキル基を有する重合性モノマーをモノマーユニットとして有する共重合体を含む、筒状構造体。
(2) 上記シリコーンモノマーは、下記の一般式(I)で示される、(1)記載の筒状構造体。
(3) 上記X1及びX2は、(メタ)アクリロイル基である、(2)記載の筒状構造体。
(4) 上記フルオロアルキル基を有する重合性モノマーは、下記の一般式(II)で示される、(1)~(3)のいずれか記載の筒状構造体。
(5) 一回反射赤外分光法を用いて上記被覆材の表面を2.5~25μmの波長、入射角45°で測定した時、以下の式1の条件を満たす、(1)~(4)のいずれか記載の筒状構造体。
I1/I2≦5.0 ・・・式1
[式中、I1は、エステル基由来のC=O伸縮振動に基づく1740~1780cm-1の吸光度を表し、I2は、アルキル基由来のC-H変角振動に基づく1430~1470cm-1の吸光度を表す。]
(6) 上記共重合体は、カルボキシル基又はヒドロキシル基を有する、(1)~(5)のいずれか記載の筒状構造体。
(7) 上記共重合体は、下記の一般式(III)で示される構造を含む、(5)又は(6)記載の筒状構造体。
(8) 上記基材は、ポリエステル、ポリウレタン又はポリテトラフルオロエチレンからなる、(1)~(7)のいずれか記載の筒状構造体。
(9) 上記筒状の基材は、経糸及び緯糸を有する筒状の織物であり、上記筒状の織物は、経糸方向の外径の差が10%以内であり、かつ、下記の式2の条件を満たす、(1)~(8)のいずれか記載の筒状構造体。
(L2-L1)/L1≧0.1 ・・・式2
[式中、L1は、応力を加えない状態で測定した時の筒状の織物の外径において、該織物の外径の最大値の5倍の距離で該織物の外周上に標線を引き、該織物の経糸方向に0.01cN/dtexの応力で圧縮した時の標線間距離を表し、L2は、該織物の経糸方向に0.01cN/dtexの応力で伸長した時の標線間距離を表す。]
(10) 上記筒状の基材は、経糸及び緯糸を有する筒状の織物であり、上記筒状の織物は、下記の式3の条件を満たす、(1)~(9)のいずれか記載の筒状構造体。
0.03≦(a-b)/a<0.2 ・・・式3
[式中、aは、経糸方向に0.01cN/dtexの応力で圧縮した時の該織物の最大外径を表し、bは、経糸方向に0.01cN/dtexの応力で伸長した時の該織物の最小外径を現す。]
(11) 生体内に埋め込み可能な医療用チューブである、(1)~(10)のいずれか記載の筒状構造体。
(12) 人工血管である、(1)~(10)のいずれか記載の筒状構造体。
含水率=((湿潤状態での重量)-(乾燥状態での重量)/(湿潤状態での重量))×100 ・・・式A
I1/I2≦5.0 ・・・式1
[式中、I1は、エステル基由来のC=O伸縮振動に基づく1740~1780cm-1の吸光度を表し、I2は、C-H変角振動に基づく1430~1470cm-1の吸光度を表す。]
(L2-L1)/L1≧0.1 ・・・式2
0.03≦(a-b)/a<0.2 ・・・式3
(変動指数c=(a-b)/a)
湯洗により、原糸油剤を落とし、経糸Bを収縮させる。処理条件は、温度80~98℃、時間15~40分が好ましい。
プレ熱セットにより、経糸Bの収縮に伴いクリンプ率が大きくなった経糸Aの形状を安定化させる。外径2.8mmの丸棒を筒状の織物に挿入し、両端を針金等で固定して、熱処理を行う。処理条件は、温度160~190℃、時間3~10分が好ましい。なお、上記丸棒の材質は、例えば、ステンレス鋼材を挙げることができる。
必要に応じて、経糸A及び緯糸Cの脱海処理を行うとともに、経糸Bの溶解除去を行う。脱海処理及び溶解除去は、下記工程で行う。
酸処理により、海島複合繊維の海成分を脆化させる。酸としては、マレイン酸を挙げることができる。処理条件は、濃度0.1~1重量%、温度100~150℃、時間10~50分が好ましい。海島複合繊維を使用しない場合は、酸処理は省くことができる。
アルカリ処理により、溶解糸及び酸処理により脆化した海島複合繊維の海成分を溶出させる。アルカリとしては、水酸化ナトリウムを挙げることができる。処理条件は、濃度0.5~2重量%、温度70~98℃、時間60~100分が好ましい。
1回目の熱セットにより、脱海処理により緩んだ経糸のクリンプを再度最大化させることを目的とする。外径3mmの丸棒を筒状の織物に挿入し、シワが入らないよう経糸方向に最大限圧縮した状態で、両端を針金等で固定して、熱処理を行う。処理条件は、温度160~190℃、時間3~10分が好ましい。なお、丸棒の材質は、例えば、ステンレス鋼材を挙げることができる。
2回目の熱セットにより、クリンプの屈曲点を残しながら縮み代を有した織物にすることを目的とするが2回目は実施しなくても良い。外径3mmの丸棒を筒状の織物に挿入し、経糸方向に20~50%伸長した状態で、両端を針金等で固定して、熱処理を行う。処理条件は、熱セット1回目より10~20℃低い温度とし、時間3~10分が好ましい。なお、上記丸棒の材質は、例えば、ステンレス鋼材を挙げることができる。
繊度は、JIS L 1013:2010 8.3.1 正量繊度(A法)に基づき測定した。フィラメント数は、JIS L 1013:2010 8.4に基づき測定した。
使用するマルチフィラメントの単糸側面をキーエンス製マイクロスコープVHX-2000にて400倍に拡大した写真をもとに測定し、μm単位で算出した。その際、偏平糸等の異形断面糸は側面が最小となる部分で測定した。
ISO7198のガイダンスに則り、テーパー度1/10以下の円錐を垂直にたて、その上に筒状の織物を径方向に切断した断面を被せるように垂直にそっと落とし、止まったサンプルの下端位置の円錐の径を測定した。経糸方向に50mm間隔で切断し、5箇所測定を行い、最大値と最小値で評価した。
筒状の織物の外径をノギスにて測定した。筒状の織物に応力を加えない状態で経糸方向に50mm間隔で5箇所測定を行い、最大値と最小値で評価した。外径の差は、最大値から最小値を引き、その値を最大値で除した値とした。
先ず、上記(4)により、織物外径の最大値(筒状の織物に応力を加えない状態で測定した時の織物外径最大部分)を求める。
応力(cN)=0.01×経糸繊度×経糸本数 ・・・式4
上記(5)と同様の手順で、筒状の織物を経糸方向に0.01cN/dtexの応力で圧縮した時の筒状の織物の外径をノギスにて測定した。試料を変えて5回測定を行い、最大値を「最大外径a(圧縮時織物外径)」とした。また、筒状の織物を経糸方向に0.01cN/dtexの応力で伸長した時の筒状の織物の外径をノギスにて測定した。試料を変えて5回測定を行い、最小値を「最小外径b(伸長時織物外径)」とした。いずれの場合も外径の測定位置は筒状の織物に記した二つの標線間の中央部と標線から5mm内側の3箇所とする。試料を5回変えて測定するため、測定は15回行う。
筒状の織物を経糸方向に切断した緯糸断面を電子顕微鏡にて150倍に拡大した写真をもとに、筒状の織物内面の隣り合う経糸の頭頂部と緯糸の頭頂部の差を測定した。試料を変えて5回測定を行い、平均値で評価した。平均値を「筒状の織物の内面凹凸」とした。
JIS L 1096:2010 8.6.1に基づき測定した。試料を平らな台上に置き、不自然なしわや張力を除いて、異なる5カ所について0.5cm間の経糸及び緯糸の本数を数え、それぞれの平均値を算出し、2.54cm当たりの本数に換算した。
被覆材のモノマー混合溶液として、以下の成分を混合した。
トリフルオロエチルアクリレート(ビスコート3F;大阪有機化学工業株式会社): 57.9重量部
2-エチルヘキシルアクリレート: 7重量部
ジメチルアミノエチルアクリレート: 0.1重量部
着色剤(Reactive Blue246): 0.02重量部
重合開始剤(“イルガキュア(登録商標)”819;チバ・スペシャルティ・ケミカルズ:0.5重量部
t-アミルアルコール: 10重量部
ポリジメチルシロキサン(FM7726、JNC株式会社、重量平均分子量29kD、数平均分子量26kD): 28重量部
ポリジメチルシロキサン(FM0721、JNC株式会社、重量平均分子量5000): 7重量部
を加え、よく混合し攪拌した。この混合物をメンブレンフィルター(0.45μm)でろ過して不溶分を除いてモノマー混合溶液を得た。
IS07198のガイダンスに則り、耐キンク性は4~15mmの範囲でキンク半径を測定した。筒状構造体をループさせていき、折れ曲がりが生じた際に内径の直径が50%未満になった時点の、筒状構造体のループ半径を半径既知の円筒状治具を用いて測定した。織成管状体自体の特性を評価するため、内圧維持は行わなかった。
被覆材の表面に対して、下記の測定条件により一回反射赤外分光(ATR)測定を実施した。
装置 :Varian7000
光源 :高輝度セラミックス
検知器 :DTGS(重水素化硫酸三グリシン)
パージ :窒素ガス
分解能 :4cm-1
積算回数:128
測定方法:一回反射型
入射角 :45°
プリズム:Ge
測定波長:2.5~25μm
各々の筒状構造体を3cmの長さに切り取り、片端にコネクターとシリコンチューブを接続、もう片端は鉗子を用いて穴を閉じた。ペリスタポンプを用いて18℃のRO水を送液し、シリコンチューブを通して筒状構造体内をRO水で満たした。次に、16Gのサーフロー留置針を用いて45°の角度で筒状構造体に穿刺、引き抜いた後、水圧が120mmHgになるよう負荷をかけ、1分間に漏れ出た漏水量の重量を測定することで、穿刺1回あたりの漏水性を算出した。続いて、用いた筒状構造体の外表面積から、8回/(外表面積:cm2)に相当する穿刺回数を算出し、すでに穿刺した穴に重ならないよう長軸方向に一列に穿刺した後、上記と同様の操作により、8回/cm2あたりの漏水性を算出した。
製織工程において、下記の経糸(経糸A及びB)並びに緯糸(緯糸C及びD)を使用した。
経糸A(海島複合繊維):ポリエチレンテレフタレート繊維、66dtex、9フィラメント(脱海処理後:52.8dtex、630フィラメント)
経糸B(溶解糸):5-ナトリウムスルホイソフタル酸を共重合した易アルカリ溶解性のポリエステル繊維、84dtex、24フィラメント
緯糸C(内層)(海島複合繊維):ポリエチレンテレフタレート繊維、66dtex、9フィラメント(脱海処理後:52.8dtex、630フィラメント)
緯糸D(外層):ポリエチレンテレフタレート繊維、56dtex、18フィラメント
処理条件を温度98℃、時間20分として、筒状の織物の湯洗を行った。
外径2.8mmの丸棒を筒状の織物に挿入し、両端を針金で固定して、熱処理を行った。処理条件は、温度180℃、時間5分であった。なお、上記丸棒の材質は、ステンレス鋼材であった。
筒状の織物について、上記経糸A及び緯糸Cの脱海処理を行うとともに、経糸Bの溶解除去を行った。
酸としては、マレイン酸を使用した。処理条件は、濃度0.2重量%、温度130℃、時間30分として、筒状の織物の酸処理を行った。
アルカリとしては、水酸化ナトリウムを使用した。処理条件は、濃度1wt%、温度80℃、時間90分として、筒状の織物のアルカリ処理を行った。
外径3mmの丸棒を筒状の織物に挿入し、経糸方向にシワが入らないよう最大限圧縮した状態で、両端を針金等で固定して、熱処理を行った。処理条件は、温度180℃、時間5分であった。なお、上記丸棒の材質は、ステンレス鋼材であった。
外径3mmの丸棒を筒状の織物に挿入し、経糸方向に30%伸長した状態で、両端を針金等で固定して、熱処理を行った。処理条件は、温度170℃、時間5分であった。なお、上記丸棒の材質はステンレス鋼材であった。得られた筒状の織物の特性(繊度、フィラメント数、単糸直径、筒状の織物の内径(最大部及び最小部)、筒状の織物の外径(最大部及び最小部)、筒状の織物の圧縮時標線距離L1、伸長時標線距離L2、最大外径a、最小外径b、変動指数(C)及び内面凹凸)を表1に示す。また、上記方法により測定したキンク半径、漏水性試験の結果を表2に示す。
参考例1において得られた筒状の織物に対し、5.0重量%過マンガン酸カリウム(和光純薬工業株式会社製)、0.6mol/L硫酸(和光純薬工業株式会社製)の水溶液に浸漬し、60℃で3時間反応させて筒状の織物を加水分解及び酸化した。次いで、0.5重量%DMT-MM(和光純薬工業株式会社製)、5.0重量%PEI(LUPASOL(登録商標) P;BASF社製)の水溶液に浸漬し、30℃で2時間反応させ、参考例1において得られた筒状の織物の内面に、PEIを縮合反応により共有結合させた。
参考例1で得られた筒状の織物5cmに直径3mmのステンレス鋼材製の丸棒6cmを挿入し、ポリプロピレンからなる直径6mm、内径4.5mm、長さ6cmの筒状モールドにステンレス鋼材製の丸棒を挿入した筒状の織物を入れ、モールドの一方の出口をゴム栓で封止した。もう一方の出口から、筒状モールドと筒状の織物の隙間に、調製したモノマー混合溶液を筒状の織物が完全に浸漬するまで注入し、蛍光ランプ(東芝、FL-6D、昼光色、6W、4本)を用いて光照射(1.01mW/cm2、20分間)して重合した。重合後、モールドごとイソプロピルアルコール中に浸漬して80℃で1時間加温した後、モールドから得られた筒状構造体をステンレス鋼材製の丸棒ごと取り出して剥離した。さらに、イソプロピルアルコールに室温、30分間浸漬した後、筒状構造体からステンレス鋼材の棒を取り外し、一晩風乾させた。得られた筒状構造体のキンク半径、漏水性及び吸光度比I1/I2の結果を表2に示す。
実施例1と同じ操作により得られた、共重合体を被覆した筒状の織物を、エタノール濃度10v/v%の水溶液に、水酸化ナトリウム濃度4.0mol/Lになるよう調製したアルカリ処理液に浸漬し、60℃で反応処理時間を1時間として静置した。反応後、筒状構造体を処理液から取りだし、RO水で3回洗浄したのち、一晩風乾させた。得られた筒状構造体のキンク半径、漏水性及び吸光度比I1/I2の結果を表2に示す。
アルカリ処理液中の水酸化ナトリウム濃度及び反応処理時間をそれぞれ、実施例3(水酸化ナトリウム濃度が2.0mol/L;反応処理時間が1時間)、実施例4(水酸化ナトリウム濃度が1.0mol/L;反応処理時間が6時間)、実施例5(水酸化ナトリウム濃度が0.5mol/L;反応処理時間が6時間)、実施例6(水酸化ナトリウム濃度が0.25mol/L;反応処理時間が6時間)、実施例7(水酸化ナトリウム濃度が0.125mol/L;反応処理時間が6時間)、実施例8(水酸化ナトリウム濃度が0.05mol/L;反応処理時間が6時間)、実施例9(水酸化ナトリウム濃度が0.01mol/L;反応処理時間が6時間)と変更した以外は、実施例2と同様の操作を実施した。得られた各筒状構造体のキンク半径、漏水性及び吸光度比I1/I2の結果を表2に示す。
参考例1と同様の操作により得られた筒状の織物5cmに、一液硬化性シリコーン(信越化学製;RTVゴム一般工業用、KE42T-330 )を均一に塗布した後、3日間風乾した。これにより、ポリエステルのみからなる基材を、シリコーンのみからなる被覆材で被覆した筒状構造体を得た。得られた筒状構造体のキンク半径及び漏水性の結果を表2に示す。
参考例1と同様の操作により得られた筒状の織物5cmに、ポリウレタンのみからなる、フィルム厚が20μmのドレッシングテープ(防水フィルムロール;株式会社共和製)を5層巻きした。これにより、ポリエステルのみからなる基材に対し、被覆材としてウレタンテープを用いて被覆した筒状構造体を得た。得られた筒状構造体のキンク半径及び漏水性の結果を表2に示す。
参考例1と同様の操作により得られた筒状の織物5cmに、生体吸収性材料として30wt%に調製したゼラチン溶液(ビーマトリックス(登録商標)ゼラチンLS-H;新田ゼラチン株式会社製)を塗布し、塗布後に4℃で1時間冷却することでゼラチンを固化させた。次いで、0.2%グルタルアルデヒド溶液中に30分間浸漬し、固化したゼラチンを架橋した後、40℃で一晩乾燥させた。これにより、ポリエステルのみからなる基材に対し、被覆材として架橋ゼラチンを被覆した筒状構造体を得た。得られた筒状構造体のキンク半径及び漏水性の結果を表2に示す。
ePTFEのみからなる、長さ5cm、内径3mm、厚み0.5mmの人工血管(ゴアテックス(登録商標);ゴア社製)を用意し、比較例4として用いた。キンク半径及び漏水性の結果を表2に示す。
比較例4で用意したePTFEのみからなる人工血管を基材として用い、実施例1と同様の操作により共重合体を被覆した。得られた筒状構造体のキンク半径及び漏水性の結果を表2に示す。
比較例4で用意したePTFEのみからなる人工血管を基材として用い、比較例1と同様の操作により基材にシリコーンを被覆し、ePTFE基材にシリコーンを被覆した筒状構造体が得られ、以下の試験の比較例5として用いた。得られた筒状構造体のキンク半径及び漏水性の結果を表2に示す。
比較例4で用意したePTFEのみからなる人工血管を基材として用い、比較例2と同様の操作によりウレタン製ドレッシングテープを巻き付けたことで、ePTFE基材にウレタンテープを被覆した筒状構造体が得られ、以下の試験の比較例6として用いた。得られた筒状構造体のキンク半径及び漏水性の結果を表2に示す。
ポリウレタンのみからなる、長さ5cm、内径6mm、厚み1.0mmの人工血管(ソラテック(登録商標);株式会社グッドマン製)を用意し、以下の試験の比較例7として用いた。キンク半径及び漏水性の結果を表2に示す。
ポリエステル、スチレン系エラストマー及びポリオレフィンの三層構造からなる、長さ5cm、内径5.6mm、厚み1.2mmの人工血管(グラシル(登録商標);テルモ株式会社製)を用意し、以下の試験の比較例8として用いた。キンク半径及び漏水性の結果を表2に示す。
Claims (12)
- 筒状の基材と、前記基材を被覆する被覆材と、を備え、
前記被覆材は、シリコーンモノマー及びフルオロアルキル基を有する重合性モノマーをモノマーユニットとして有する共重合体を含む、筒状構造体。 - 前記X1及びX2は、(メタ)アクリロイル基である、請求項2記載の筒状構造体。
- 一回反射赤外分光法を用いて前記被覆材の表面を2.5~25μmの波長、入射角45°で測定した時、以下の式1の条件を満たす、請求項1~4のいずれか一項記載の筒状構造体。
I1/I2≦5.0 ・・・式1
[式中、I1は、エステル基由来のC=O伸縮振動に基づく1740~1780cm-1の吸光度を表し、I2は、アルキル基由来のC-H変角振動に基づく1430~1470cm-1の吸光度を表す。] - 前記共重合体は、カルボキシル基又はヒドロキシル基を有する、請求項1~5のいずれか一項記載の筒状構造体。
- 前記基材は、ポリエステル、ポリウレタン又はポリテトラフルオロエチレンからなる、請求項1~7のいずれか一項記載の筒状構造体。
- 前記筒状の基材は、経糸及び緯糸を有する筒状の織物であり、
前記筒状の織物は、経糸方向の外径の差が10%以内であり、かつ、下記の式2の条件を満たす、請求項1~8のいずれか一項記載の筒状構造体。
(L2-L1)/L1≧0.1 ・・・式2
[式中、L1は、応力を加えない状態で測定した時の筒状の織物の外径において、該織物の外径の最大値の5倍の距離で該織物の外周上に標線を引き、該織物の経糸方向に0.01cN/dtexの応力で圧縮した時の標線間距離を表し、L2は、該織物の経糸方向に0.01cN/dtexの応力で伸長した時の標線間距離を表す。] - 前記筒状の基材は、経糸及び緯糸を有する筒状の織物であり、
前記筒状の織物は、下記の式3の条件を満たす、請求項1~9のいずれか一項記載の筒状構造体。
0.03≦(a-b)/a<0.2 ・・・式3
[式中、aは、経糸方向に0.01cN/dtexの応力で圧縮した時の該織物の最大外径を表し、bは、経糸方向に0.01cN/dtexの応力で伸長した時の該織物の最小外径を現す。] - 生体内に埋め込み可能な医療用チューブである、請求項1~10のいずれか一項記載の筒状構造体。
- 人工血管である、請求項1~10のいずれか一項記載の筒状構造体。
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18775244.9A EP3603573B1 (en) | 2017-03-31 | 2018-03-30 | Cylindrical structure |
| CA3058121A CA3058121A1 (en) | 2017-03-31 | 2018-03-30 | Cylindrical structure |
| RU2019133671A RU2019133671A (ru) | 2017-03-31 | 2018-03-30 | Цилиндрическая структура |
| BR112019016808A BR112019016808A2 (pt) | 2017-03-31 | 2018-03-30 | estrutura cilíndrica |
| JP2018517243A JP7157930B2 (ja) | 2017-03-31 | 2018-03-30 | 筒状構造体 |
| KR1020197031420A KR20190130618A (ko) | 2017-03-31 | 2018-03-30 | 통 형상 구조체 |
| US16/497,745 US12053366B2 (en) | 2017-03-31 | 2018-03-30 | Cylindrical structure |
| CN201880021604.0A CN110461274B (zh) | 2017-03-31 | 2018-03-30 | 筒状结构体 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017-070163 | 2017-03-31 | ||
| JP2017070163 | 2017-03-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2018181918A1 true WO2018181918A1 (ja) | 2018-10-04 |
Family
ID=63676272
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2018/013681 Ceased WO2018181918A1 (ja) | 2017-03-31 | 2018-03-30 | 筒状構造体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12053366B2 (ja) |
| EP (1) | EP3603573B1 (ja) |
| JP (1) | JP7157930B2 (ja) |
| KR (1) | KR20190130618A (ja) |
| CN (1) | CN110461274B (ja) |
| BR (1) | BR112019016808A2 (ja) |
| CA (1) | CA3058121A1 (ja) |
| RU (1) | RU2019133671A (ja) |
| TW (1) | TW201841592A (ja) |
| WO (1) | WO2018181918A1 (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020045611A1 (ja) * | 2018-08-31 | 2020-03-05 | 東レ株式会社 | インプラント用の筒状体 |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020095715A1 (ja) | 2018-11-08 | 2020-05-14 | デンカ株式会社 | 樹脂組成物及びそれを用いた生体モデル |
| EP3879512B1 (en) * | 2018-11-08 | 2023-02-22 | Denka Company Limited | Artificial blood vessel |
Citations (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS497612B1 (ja) | 1969-02-07 | 1974-02-21 | ||
| JPS57176244U (ja) * | 1981-04-30 | 1982-11-08 | ||
| JPS591868B2 (ja) | 1980-02-15 | 1984-01-14 | 松下電工株式会社 | 隅木飾り |
| JPH0298352A (ja) | 1988-10-05 | 1990-04-10 | Kanebo Ltd | 内シャント用人工血管 |
| JPH07265338A (ja) | 1994-03-31 | 1995-10-17 | Nippon Zeon Co Ltd | 人工血管 |
| JPH0824686B2 (ja) | 1987-09-01 | 1996-03-13 | 東レ株式会社 | 高機能人工血管 |
| JPH0971749A (ja) * | 1995-07-03 | 1997-03-18 | Toray Ind Inc | 生物付着防止性重合体及びその製造方法並びに生物付着防止性海洋構造体 |
| JP2970320B2 (ja) | 1993-06-07 | 1999-11-02 | 住友電気工業株式会社 | 人工血管 |
| JP2001021093A (ja) * | 1999-07-07 | 2001-01-26 | Bridgestone Corp | サブマリンホース |
| JP2005152178A (ja) | 2003-11-25 | 2005-06-16 | Terumo Corp | 人工血管 |
| JP2005152181A (ja) | 2003-11-25 | 2005-06-16 | Terumo Corp | 埋込み可能な管状体治療具 |
| JP2006511282A (ja) | 2002-12-23 | 2006-04-06 | ボストン・サイエンティフィック・リミテッド | 自己シール特性が改良されたマルチ管腔血管グラフト |
| JP3799626B2 (ja) | 1995-04-25 | 2006-07-19 | 有限会社ナイセム | 心臓血管修復材及びその製造方法 |
| WO2008032758A1 (fr) | 2006-09-15 | 2008-03-20 | Toray Industries, Inc. | Substrat et procédé pour la production de celui-ci |
| JP4152075B2 (ja) | 1998-09-09 | 2008-09-17 | カルメダ アクチボラゲット | 表面改質物質を調整する新方法 |
| JP2009122457A (ja) * | 2007-11-15 | 2009-06-04 | Tachibana Shoten Co Ltd | 弾性部材、トナー定着部体、定着装置及び弾性部材の製造方法 |
| JP2009545333A (ja) | 2006-05-12 | 2009-12-24 | ゴア エンタープライズ ホールディングス,インコーポレイティド | 物理的操作または殺菌の後に大きな生物活性を有する固定化された生物活性物質 |
| JP4461217B2 (ja) | 2001-01-23 | 2010-05-12 | イェナフィン ゲーエムベーハー | オリゴまたはポリアルキレングリコール結合トロンビン阻害剤 |
| WO2012176861A1 (ja) | 2011-06-23 | 2012-12-27 | 東レ株式会社 | 医療材料 |
| JP2015501173A (ja) | 2011-10-07 | 2015-01-15 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティドW.L. Gore & Associates, Incorporated | 破裂可能でかつ再シール可能なグラフト |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3217579A1 (de) | 1982-05-11 | 1983-11-17 | Skf Kugellagerfabriken Gmbh, 8720 Schweinfurt | Laufrolle |
| US4816339A (en) | 1987-04-28 | 1989-03-28 | Baxter International Inc. | Multi-layered poly(tetrafluoroethylene)/elastomer materials useful for in vivo implantation |
| JP3591868B2 (ja) | 1994-05-10 | 2004-11-24 | テルモ株式会社 | 人工補綴物 |
| CN102058450B (zh) * | 2010-11-26 | 2012-07-18 | 哈尔滨工业大学 | 一种用于血管破裂修复的超疏水血管支架的制备方法 |
| EP2745854B1 (en) * | 2011-08-17 | 2018-02-07 | Toray Industries, Inc. | Medical device, and method for producing same |
| JP5820489B2 (ja) * | 2014-01-06 | 2015-11-24 | 住友ゴム工業株式会社 | 表面改質方法及び表面改質弾性体 |
| CN105979910B (zh) * | 2014-02-12 | 2018-05-18 | 东丽株式会社 | 人工血管 |
-
2018
- 2018-03-30 CA CA3058121A patent/CA3058121A1/en active Pending
- 2018-03-30 RU RU2019133671A patent/RU2019133671A/ru not_active Application Discontinuation
- 2018-03-30 JP JP2018517243A patent/JP7157930B2/ja active Active
- 2018-03-30 CN CN201880021604.0A patent/CN110461274B/zh active Active
- 2018-03-30 EP EP18775244.9A patent/EP3603573B1/en active Active
- 2018-03-30 KR KR1020197031420A patent/KR20190130618A/ko not_active Withdrawn
- 2018-03-30 BR BR112019016808A patent/BR112019016808A2/pt not_active Application Discontinuation
- 2018-03-30 US US16/497,745 patent/US12053366B2/en active Active
- 2018-03-30 WO PCT/JP2018/013681 patent/WO2018181918A1/ja not_active Ceased
- 2018-03-31 TW TW107111445A patent/TW201841592A/zh unknown
Patent Citations (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS497612B1 (ja) | 1969-02-07 | 1974-02-21 | ||
| JPS591868B2 (ja) | 1980-02-15 | 1984-01-14 | 松下電工株式会社 | 隅木飾り |
| JPS57176244U (ja) * | 1981-04-30 | 1982-11-08 | ||
| JPH0824686B2 (ja) | 1987-09-01 | 1996-03-13 | 東レ株式会社 | 高機能人工血管 |
| JPH0298352A (ja) | 1988-10-05 | 1990-04-10 | Kanebo Ltd | 内シャント用人工血管 |
| JP2970320B2 (ja) | 1993-06-07 | 1999-11-02 | 住友電気工業株式会社 | 人工血管 |
| JPH07265338A (ja) | 1994-03-31 | 1995-10-17 | Nippon Zeon Co Ltd | 人工血管 |
| JP3799626B2 (ja) | 1995-04-25 | 2006-07-19 | 有限会社ナイセム | 心臓血管修復材及びその製造方法 |
| JPH0971749A (ja) * | 1995-07-03 | 1997-03-18 | Toray Ind Inc | 生物付着防止性重合体及びその製造方法並びに生物付着防止性海洋構造体 |
| JP4152075B2 (ja) | 1998-09-09 | 2008-09-17 | カルメダ アクチボラゲット | 表面改質物質を調整する新方法 |
| JP2001021093A (ja) * | 1999-07-07 | 2001-01-26 | Bridgestone Corp | サブマリンホース |
| JP4461217B2 (ja) | 2001-01-23 | 2010-05-12 | イェナフィン ゲーエムベーハー | オリゴまたはポリアルキレングリコール結合トロンビン阻害剤 |
| JP2006511282A (ja) | 2002-12-23 | 2006-04-06 | ボストン・サイエンティフィック・リミテッド | 自己シール特性が改良されたマルチ管腔血管グラフト |
| JP2005152181A (ja) | 2003-11-25 | 2005-06-16 | Terumo Corp | 埋込み可能な管状体治療具 |
| JP2005152178A (ja) | 2003-11-25 | 2005-06-16 | Terumo Corp | 人工血管 |
| JP2009545333A (ja) | 2006-05-12 | 2009-12-24 | ゴア エンタープライズ ホールディングス,インコーポレイティド | 物理的操作または殺菌の後に大きな生物活性を有する固定化された生物活性物質 |
| WO2008032758A1 (fr) | 2006-09-15 | 2008-03-20 | Toray Industries, Inc. | Substrat et procédé pour la production de celui-ci |
| JP2009122457A (ja) * | 2007-11-15 | 2009-06-04 | Tachibana Shoten Co Ltd | 弾性部材、トナー定着部体、定着装置及び弾性部材の製造方法 |
| WO2012176861A1 (ja) | 2011-06-23 | 2012-12-27 | 東レ株式会社 | 医療材料 |
| JP2015501173A (ja) | 2011-10-07 | 2015-01-15 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティドW.L. Gore & Associates, Incorporated | 破裂可能でかつ再シール可能なグラフト |
Non-Patent Citations (1)
| Title |
|---|
| See also references of EP3603573A4 |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020045611A1 (ja) * | 2018-08-31 | 2020-03-05 | 東レ株式会社 | インプラント用の筒状体 |
| JPWO2020045611A1 (ja) * | 2018-08-31 | 2021-08-12 | 東レ株式会社 | インプラント用の筒状体 |
| JP7290110B2 (ja) | 2018-08-31 | 2023-06-13 | 東レ株式会社 | インプラント用の筒状体 |
| US12115285B2 (en) | 2018-08-31 | 2024-10-15 | Toray Industries, Inc. | Cylindrical member for implantation |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3603573A1 (en) | 2020-02-05 |
| KR20190130618A (ko) | 2019-11-22 |
| CA3058121A1 (en) | 2018-10-04 |
| CN110461274A (zh) | 2019-11-15 |
| EP3603573A4 (en) | 2020-12-09 |
| RU2019133671A (ru) | 2021-04-30 |
| EP3603573B1 (en) | 2023-03-22 |
| US20200022799A1 (en) | 2020-01-23 |
| RU2019133671A3 (ja) | 2021-07-02 |
| CN110461274B (zh) | 2022-09-02 |
| US12053366B2 (en) | 2024-08-06 |
| JPWO2018181918A1 (ja) | 2020-02-06 |
| TW201841592A (zh) | 2018-12-01 |
| JP7157930B2 (ja) | 2022-10-21 |
| BR112019016808A2 (pt) | 2020-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4383851B2 (ja) | 多糖類生体材料及びその使用 | |
| Mao et al. | Various approaches to modify biomaterial surfaces for improving hemocompatibility | |
| JP6863295B2 (ja) | 筒状織物 | |
| AU778893B2 (en) | Process for impregnating a porous material with a cross-linkable composition | |
| US20020169493A1 (en) | Anti-thrombogenic coatings for biomedical devices | |
| KR20000069693A (ko) | 반응성 피막 | |
| JPH06502781A (ja) | 表面改質した外科用機器、器具、インプラント、コンタクトレンズおよびその類似物 | |
| WO2012006135A2 (en) | Fluorinated polymers and lubricious coatings | |
| JP7157930B2 (ja) | 筒状構造体 | |
| WO2016190202A1 (ja) | 筒状織物構造体 | |
| KR20230038787A (ko) | 오염 방지 이식 가능 재료 및 제조 방법 | |
| CN105979910B (zh) | 人工血管 | |
| Dizon et al. | Dopamine-induced surface zwitterionization of expanded poly (tetrafluoroethylene) for constructing thermostable bioinert materials | |
| KR20170134571A (ko) | 항혈전성 재료 | |
| PAYNTER et al. | The Atrium Plasma TFE® Arterial Prosthesis: Physical and Chemical Characterization | |
| TATEISHI et al. | Antithrombogenicity of poly (ether ether ketone) surface prepared by self-initiated surface graft polymerization of 2-methacryloyloxyethyl phosphorylcholine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ENP | Entry into the national phase |
Ref document number: 2018517243 Country of ref document: JP Kind code of ref document: A |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18775244 Country of ref document: EP Kind code of ref document: A1 |
|
| REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112019016808 Country of ref document: BR |
|
| ENP | Entry into the national phase |
Ref document number: 3058121 Country of ref document: CA |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| ENP | Entry into the national phase |
Ref document number: 20197031420 Country of ref document: KR Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2018775244 Country of ref document: EP |
|
| ENP | Entry into the national phase |
Ref document number: 2018775244 Country of ref document: EP Effective date: 20191031 |
|
| ENP | Entry into the national phase |
Ref document number: 112019016808 Country of ref document: BR Kind code of ref document: A2 Effective date: 20190813 |